Smoking initiation and schizophrenia: A replication study in a Chinese Han population

Schizophrenia Research

Volumn 119, Issue 1-3, 2010, Pages 110-114

  Zhang, Xiang Yang ^a   Li, Cun Bao ^b   Li, Min ^c   Zheng, You Lan ^c   Zhang, Chong Xi ^d   Yan, Quan Zhi ^b   Liu, Wen Zhong ^b   Kang, Yi Min ^b   Wang, Fan ^e   Chen, Da Chun ^e   Xiu, Mei Hong ^e   Kosten, Thomas R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

^e BEIJING HUILONGGUAN HOSPITAL   (China)

Author keywords

Cumulative hazard curves; Nicotine; Schizophrenia; Smoking initiation; Survival analysis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT ATTITUDE; POPULATION RESEARCH; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING; SMOKING HABIT; SURVIVAL;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHRONIC DISEASE; CROSS-CULTURAL COMPARISON; HEALTH SURVEYS; HOSPITALS, PSYCHIATRIC; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; SCHIZOPHRENIA; SMOKING; SURVIVAL ANALYSIS;

EID: 77952669276     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.11.012     Document Type: Article

References (29)

1. Beratis S., Katrivanou A., Gourzis P. Factors affecting smoking in schizophrenia. Compr. Psychiatry 2001, 42(5):393-402.
2. Chong S.A., Choo H.L. Smoking among Chinese patients with schizophrenia. Aust. N. Z. J. Psychiatry 1996, 30:350-353.
3. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am. J. Psychiatry 1998, 155(11):1490-1501.
4. de Leon J. Smoking and vulnerability for schizophrenia. Schizophr. Bull. 1996, 22(3):405-409.
5. de Leon J., Diaz F. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 2005, 76:135-157.
6. de Leon J., Becoña E., Gurpegui M., Gonzalez-Pinto A., Diaz F.J. The association between high nicotine dependence and severe mental illness may be consistent across countries. J. Clin. Psychiatry 2002, 63(9):812-816.
7. de Leon J., Diaz F.J., Rogers T., Browne D., Dinsmore L., Ghosheh O.H., Dwoskin L.P., Crooks P.A. Total cotinine in plasma: a stable biomarker for exposure to tobacco smoke. J. Clin. Psychopharmacol. 2002, 22(5):496-501.
8. de Leon J., Diaz F.J., Josiassen R.C., Cooper T.B., Simpson G.M. Does clozapine decrease smoking?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(5):757-762.
9. de Leon J., Susce M.T., Diaz F.J., Rendon D.M., Velásquez D.M. Variables associated with alcohol, drug, and daily smoking cessation in patients with severe mental illnesses. J. Clin. Psychiatry 2005, 66(11):1447-1455.
10. Diaz F.J., Velásquez D.M., Susce M.T., de Leon J. The association between schizophrenia and smoking: unexplained by either the illness or the prodromal period. Schizophr. Res. 2008, 104(1-3):214-219.
11. Elkhazen C., Chauchot F., Canceil O., Krebs M.O., Baylé F.J. Prodromal symptoms of schizophrenia. Encephale 2003, 29(6):469-477.
12. Esterberg M.L., Jones E.M., Compton M.T., Walker E.F. Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls. Schizophr. Res. 2007, 97(1-3):6-13.
13. Fagerström K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 1978, 3(3-4):235-241.
14. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(2):587-592.
15. Goff D.C., Henderson D.C., Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry 1992, 149:1189-1194.
16. Gurpegui M., Martínez-Ortega J.M., Aguilar M.C., Diaz F.J., Quintana H.M., de Leon J. Smoking initiation and schizophrenia: a replication study in a Spanish sample. Schizophr. Res. 2005, 76(1):113-118.
17. Hao W., Young D., Li L., Xiao S. Psychoactive substance use in three sites in China: gender differences and related factors. Psychiatry Clin. Neurosci. 1998, 52(Suppl):S324-S328.
18. Kelly C., McCreadie R.G. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am. J. Psychiatry 1999, 156(11):1751-1757.
19. Klein J.P., Moeschberger M.L. Survival Analysis: Techniques for Censored and Truncated Regression 1997, Springer-Verlag, NY.
20. Lee S., Guo W.J., Tsang A., Huang Y.Q., He Y.L., Kessler R.C. Prevalence and correlates of active and ever-smokers in metropolitan China. Addict. Behav. 2009, 34(11):969-972.
21. Leonard S., Gault J., Hopkins J., Logel J., Vianzon R., Short M., Drebing C., Berger R., Venn D., Sirota P., Zerbe G., Olincy A., Ross R.G., Adler L.E., Freedman R. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry 2002, 59(12):1085-1096.
22. Liao D.L., Yang J.Y., Lee S.M., Chen H., Tsai S.J. Smoking in chronic schizophrenic inpatients in Taiwan. Neuropsychobiology 2002, 45(4):172-175.
23. LLerena A., de la Rubia A., Peñas-Lledó E.M., Diaz F.J., de Leon J. Schizophrenia and tobacco smoking in a Spanish psychiatric hospital. Schizophr. Res. 2003, 60(2-3):313-317.
24. McGlashan T.H., Zipursky R.B., Perkins D., Addington J., Miller T.J., Woods S.W., Hawkins K.A., Hoffman R., Lindborg S., Tohen M., Breier A. The PRIME North America randomized double blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr. Res. 2003, 61(1):7-18.
25. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 1962, 10:799-812.
26. Tang Y.L., Gillespie C.F., Epstein M.P., Mao P.X., Jiang F., Chen Q., Cai Z.J., Mitchell P.B. Gender differences in 542 Chinese inpatients with schizophrenia. Schizophr. Res. 2007, 97:88-96.
27. Uzun O., Cansever A., Basoǧlu C., Ozşahin A. Smoking and substance abuse in outpatients with schizophrenia: a 2-year follow-up study in Turkey. Drug Alcohol Depend. 2003, 70(2):187-192.
28. Wiles N.J., Zammit S., Bebbington P., Singleton N., Meltzer H., Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br. J. Psychiatry 2006, 188:519-526.
29. Ziedonis D.M., Kosten T.R., Glazer W.M., Frances R.J. Nicotine dependence and schizophrenia. Hosp. Community Psychiatry 1994, 45:204-206.